Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALKEM LABORATORIES ABBOTT INDIA/
ALKEM LABORATORIES
 
P/E (TTM) x 50.0 37.5 133.2% View Chart
P/BV x 18.2 6.5 278.7% View Chart
Dividend Yield % 1.2 1.0 119.2%  

Financials

 ABBOTT INDIA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
ALKEM LABORATORIES
Mar-23
ABBOTT INDIA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs22,4823,625 620.2%   
Low Rs16,1562,835 569.9%   
Sales per share (Unadj.) Rs2,517.0970.1 259.5%  
Earnings per share (Unadj.) Rs446.884.2 530.6%  
Cash flow per share (Unadj.) Rs479.7110.2 435.4%  
Dividends per share (Unadj.) Rs325.0050.00 650.0%  
Avg Dividend yield %1.71.5 108.7%  
Book value per share (Unadj.) Rs1,480.5756.4 195.7%  
Shares outstanding (eoy) m21.25119.57 17.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.73.3 230.5%   
Avg P/E ratio x43.238.4 112.7%  
P/CF ratio (eoy) x40.329.3 137.4%  
Price / Book Value ratio x13.04.3 305.6%  
Dividend payout %72.759.4 122.5%   
Avg Mkt Cap Rs m410,513386,207 106.3%   
No. of employees `000NANA-   
Total wages/salary Rs m5,63621,314 26.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,487115,993 46.1%  
Other income Rs m1,5432,161 71.4%   
Total revenues Rs m55,030118,153 46.6%   
Gross profit Rs m12,05515,065 80.0%  
Depreciation Rs m7003,104 22.5%   
Interest Rs m1601,074 14.9%   
Profit before tax Rs m12,73813,048 97.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,2442,980 108.9%   
Profit after tax Rs m9,49410,068 94.3%  
Gross profit margin %22.513.0 173.5%  
Effective tax rate %25.522.8 111.5%   
Net profit margin %17.88.7 204.5%  
BALANCE SHEET DATA
Current assets Rs m30,25186,064 35.1%   
Current liabilities Rs m12,06037,071 32.5%   
Net working cap to sales %34.042.2 80.5%  
Current ratio x2.52.3 108.0%  
Inventory Days Days8733 266.6%  
Debtors Days Days267 3.2%  
Net fixed assets Rs m15,13537,245 40.6%   
Share capital Rs m213239 88.9%   
"Free" reserves Rs m31,24890,208 34.6%   
Net worth Rs m31,46090,447 34.8%   
Long term debt Rs m00-   
Total assets Rs m45,386124,541 36.4%  
Interest coverage x80.713.2 613.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.20.9 126.5%   
Return on assets %21.38.9 237.8%  
Return on equity %30.211.1 271.1%  
Return on capital %41.015.6 262.6%  
Exports to sales %0.414.6 2.8%   
Imports to sales %10.80-   
Exports (fob) Rs m22116,916 1.3%   
Imports (cif) Rs m5,765NA-   
Fx inflow Rs m31016,916 1.8%   
Fx outflow Rs m5,8184,190 138.9%   
Net fx Rs m-5,50812,727 -43.3%   
CASH FLOW
From Operations Rs m8,93416,825 53.1%  
From Investments Rs m-1,4771,128 -130.9%  
From Financial Activity Rs m-6,387-17,608 36.3%  
Net Cashflow Rs m1,070416 257.0%  

Share Holding

Indian Promoters % 0.0 56.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 24.4 36.6%  
FIIs % 0.2 8.5 2.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 43.3 57.8%  
Shareholders   72,252 65,184 110.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs ALKEM LABORATORIES Share Price Performance

Period Abbott India ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 0.74% -1.18% 1.18%
1-Month -5.97% -0.99% -0.75%
1-Year 24.80% 52.26% 61.82%
3-Year CAGR 21.40% 21.70% 18.16%
5-Year CAGR 29.91% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Abbott India, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.